Market research
SMSLIFE.NSE SMS Lifesciences India Limited
NSE INR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 4B
- P/E ratio
- 22.05
- Analyst target
- Not available
- Dividend yield
- 0.0%
- Beta
- 0.31
Community
Investor discussion
1 comment
Sign in to join the SMSLIFE.NSE discussion.
5 years, 5 months ago
SMS Lifesciences India Limited is currently in a long term uptrend where the price is trading 25.0% above its 200 day moving average.
From a valuation standpoint, the stock is 85.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
SMS Lifesciences India Limited's total revenue rose by 42.9% to $666M since the same quarter in the previous year.
Its net income has increased by 894.7% to $27M since the same quarter in the previous year.
Finally, its free cash flow fell by 118.9% to $-13M since the same quarter in the previous year.
Based on the above factors, SMS Lifesciences India Limited gets an overall score of 4/5.